The partnership aimed at reducing the spread of HIV/AIDs in Buggala Island. Margret Namanda, the KAFOPHAN Chairperson, says the partnership is timely because the HIV prevalence rate in Kalangala has increased during COVID-19 lockdown from 28% to 32%.
Kalangala
Infrastructure Services Limited-KIS has pledged to provide Shillings 57
million for HIV testing and provision of Anti-Retroviral drugs (ARVs) to people
on Buggala Island in Kalangala District.
The money will be provided in
three quarters this financial year, according to a Memorandum of Understanding
signed between Kalangala District Forum for People Living with HIV/AIDs Network
(KAFOPHAN) and Kalangala Infrastructure Services Limited (KIS).
The
partnership is aimed at reducing the spread of HIV/AIDs in Buggala Island. Margret
Namanda, the KAFOPHAN Chairperson, says the partnership is timely because the
HIV prevalence rate in Kalangala has increased during COVID-19
lockdown from 28% to 32%.
The Shillings 57 million grant is expected to
avail anti-retroviral drugs for over 1,000 people living with HIV/AIDs on
Buggala Island. Henry Kizito,
Coordinator KAFOPHAN says the partnership aims at availing information
using different media to the Kalangala Community on the prevention of HIV/AIDs.
The grant will also benefit other people besides those within KAFOPHAN circles and KIS staff members.
//Cue in:"Enkwatagana eno wakati...
Cue out:...nakawuka ka mukenenya,//
Edward Ntambi,
the KIS Marketing, says the program is part of the company's social corporate
responsibility to work with other organizations to improve the wellbeing of the
local community.
Samuel Nkuba
Freelancer